Avanos Medical (AVNS) Total Current Liabilities (2013 - 2026)

Avanos Medical has reported Total Current Liabilities for 14 years, with the latest figure at $131.2 million in Q1 2026.

• Quarterly Total Current Liabilities fell 4.37% year-over-year to $131.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.2 million (down 4.37% YoY) and the FY2025 annual result came in at $165.2 million, changed 0.42% from the prior year.
• Total Current Liabilities retreated to $131.2 million in Q1 2026 per AVNS's latest filing, from $165.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $234.6 million in Q4 2023 and troughed at $131.2 million in Q1 2026.
• A 5-year average of $170.0 million and a median of $162.3 million in 2022 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 37.21% in 2022, then plunged 35.35% in 2025.
• Over 5 years, Total Current Liabilities stood at $191.0 million in 2022, then grew by 22.83% to $234.6 million in 2023, then fell by 29.28% to $165.9 million in 2024, then declined by 0.42% to $165.2 million in 2025, then fell by 20.58% to $131.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $131.2 million, $165.2 million, and $147.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.